Genae establishes offices in London to provide high quality research services on global scale
Published on July 31, 2014 at 10:57 AM
genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae UK in London.
The United Kingdom has one of the largest medical device markets in the world. It was valued at USD 8.9 billion in 2012 and it is projected to increase by a CAGR of 6.0% until 2017. Health expenditure was estimated at USD 234 billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, market growth rates over the coming years will be positive.
"The mature and high value medical device market in Western Europe is wealthy and developed. The friction between attempts to contain health costs and a desire to remain at the forefront of technological innovation leads to an increased demand for efficiencies. For example: medical devices that facilitate minimally invasive therapies to ensure a faster turnaround of patients." said Bart Segers, CEO at genae. "The incorporation of genae UK is a logical step in our commitment to provide high quality research services on a global scale."
London is a leading global city with many strengths that contribute to its prominence. It is one of the world's leading financial centers and its universities form the largest concentration of higher education in Europe. London has a diverse range of people and cultures and has one of the largest city airport and transportation systems, measured by passenger traffic.